|
1
|
McGlynn KA, Petrick JL and London WT:
Global epidemiology of hepatocellular carcinoma: An emphasis on
demographic and regional variability. Clin Liver Dis. 19:223–238.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zetter BR: Angiogenesis and tumor
metastasis. Annu Rev Med. 49:407–424. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29 6 Suppl 16:S15–S18. 2002.
View Article : Google Scholar
|
|
4
|
Volpert OV, Dameron KM and Bouck N:
Sequential development of an angiogenic phenotype by human
fibroblasts progressing to tumorigenicity. Oncogene. 14:1495–1502.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liberman J, Sartelet H, Flahaut M,
Mühlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM and
Gross N: Involvement of the CXCR7/CXCR4/CXCL12 axis in the
malignant progression of human neuroblastoma. PLoS One.
7:e436652012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Shiozawa Y, Wang J, Wang Y, Jung
Y, Pienta KJ, Mehra R, Loberg R and Taichman RS: The role of
CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate
cancer. J Biol Chem. 283:4283–4294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maishi N, Ohga N, Hida Y, Akiyama K,
Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M
and Hida K: CXCR7: a novel tumor endothelial marker in renal cell
carcinoma. Pathol Int. 62:309–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamada K, Maishi N, Akiyama K, Alam Towfik
M, Ohga N, Kawamoto T, Shindoh M, Takahashi N, Kamiyama T, Hida Y,
et al: CXCL12-CXCR7 axis is important for tumor endothelial cell
angiogenic property. Int J Cancer. 137:2825–2836. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Teng F, Wang G and Nie Z:
Overexpression of CXCR7 induces angiogenic capacity of human
hepatocellular carcinoma cells via the AKT signaling pathway. Oncol
Rep. 36:2275–2281. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu C, Shen SQ, Cui ZH, Chen ZB and Li W:
Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial
cells. World J Gastroenterol. 21:5884–5892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao Z, Zheng L, Zhao J, Zhuang Q, Hong Z
and Lin W: Anti-angiogenic effect of Livistona chinensis seed
extract in vitro and in vivo. Oncol Lett. 14:7565–7570.
2017.PubMed/NCBI
|
|
12
|
Wani N, Nasser MW, Ahirwar DK, Zhao H,
Miao Z, Shilo K and Ganju RK: C-X-C motif chemokine 12/C-X-C
chemokine receptor type 7 signaling regulates breast cancer growth
and metastasis by modulating the tumor microenvironment. Breast
Cancer Res. 16:R542014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hao M, Zheng J, Hou K and Wang J, Chen X,
Lu X, Bo J, Xu C, Shen K and Wang J: Role of chemokine receptor
CXCR7 in bladder cancer progression. Biochem Pharmacol. 84:204–214.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li F, Gao L, Jiang Q, Wang Z, Dong B, Yan
T and Chen X: Radiation enhances the invasion abilities of
pulmonary adenocarcinoma cells via STAT3. Mol Med Rep. 7:1883–1888.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hida K, Maishi N, Torii C and Hida Y:
Tumor angiogenesis-characteristics of tumor endothelial cells. Int
J Clin Oncol. 21:206–212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miao Z, Luker KE, Summers BC, Berahovich
R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A,
Luker GD, et al: CXCR7 (RDC1) promotes breast and lung tumor growth
in vivo and is expressed on tumor-associated vasculature. Proc Natl
Acad Sci USA. 104:15735–15740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu YC, Tang SJ, Sun GH and Sun KH: CXCR7
mediates TGFβ1-promoted EMT and tumor-initiating features in lung
cancer. Oncogene. 35:2123–2132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu H, Zhang L and Liu P: CXCR7 signaling
induced epithelial-mesenchymal transition by AKT and ERK pathways
in epithelial ovarian carcinomas. Tumour Biol. 36:1679–1683. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin L, Han MM, Wang F, Xu LL, Yu HX and
Yang PY: CXCR7 stimulates MAPK signaling to regulate hepatocellular
carcinoma progression. Cell Death Dis. 5:e14882014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Shea JJ, Holland SM and Staudt LM: JAKs
and STATs in immunity, immunodeficiency, and cancer. N Engl J Med.
368:161–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xuan X, Li S, Lou X, Zheng X, Li Y, Wang
F, Gao Y, Zhang H, He H and Zeng Q: Stat3 promotes invasion of
esophageal squamous cell carcinoma through up-regulation of MMP2.
Mol Biol Rep. 42:907–915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao G, Zhu G, Huang Y, Zheng W, Hua J,
Yang S, Zhuang J and Ye J: IL-6 mediates the signal pathway of
JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis
in gastric cancer. Oncol Rep. 35:1787–1795. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Qiu W, Zhang G, Xu S, Gao Q and
Yang Z: MicroRNA-204 targets JAK2 in breast cancer and induces cell
apoptosis through the STAT3/BCl-2/survivin pathway. Int J Clin Exp
Pathol. 8:5017–5025. 2015.PubMed/NCBI
|
